(Circulation. 1996;94:928-931.)
© 1996 American Heart Association, Inc.
Articles |
the British Heart Foundation Cardiovascular Pathology Unit, St George's Hospital Medical School, London, United Kingdom.
Correspondence to Dr M.J. Davies, British Heart Foundation Cardiovascular Pathology Unit, St George's Hospital Medical School, Cranmer Terrace, London SW17 ORE, UK.
| Abstract |
|---|
|
|
|---|
Methods and Results Atherosclerotic coronary plaques (n=160) were obtained from 31 subjects who died suddenly of ischemic heart disease. In coronary arteries perfused with formol saline at a pressure of 100 mm Hg, stenosis was measured by comparison of the minimal lumen size at the site of a plaque with that of the lumen in an adjacent normal segment of artery. Plaque size, the size of the lipid core, and the thickness of the cap were measured in histological sections. Lipid core size ranged from 0% to 82% of overall plaque size. Seventeen percent of plaques had a core size of >50%. Linear regression showed no relation of core size to stenosis (r=.21). Absolute plaque size bore no relation to core size (r=.14). Minimal cap thickness was not related to core size (r=.06). Ten percent of plaques predicted to be angiographically invisible had cores of >50%.
Conclusions Two major determinants of plaque vulnerability, core size and cap thickness, are not statistically related. Neither of these two factors that confer vulnerability are related to absolute plaque size or to the degree of stenosis.
Key Words: plaque stenosis coronary disease
| Introduction |
|---|
|
|
|---|
The ways in which plaques with a lipid core and a fibromuscular cap containing collagen (designated as types IV or Va by the Committee on Vascular Lesions of the American Heart Association4 ) progress to cause symptoms is of major interest. It is established that disruption of a type IV or Va atherosclerotic plaque is the event that initiates the coronary thrombi, which in turn causes both the crescendo form of unstable angina and acute myocardial infarction. This view is the culmination of work on necropsy material,5 6 7 8 9 the angiographic characteristics of the culprit lesion,10 11 the use of angioscopy,12 and the success of thrombolytic therapy in reopening occluded arteries in acute infarction.
The morphological characteristics of plaques that are vulnerable and have a high risk of disruption have been inferred from analysis of lesions that have already undergone disruption. Observational studies by pathologists using both necropsy and atherectomy material show that plaques that cause thrombosis are rich in lipid.13 14 15 The lipid core of such plaques occupies a high proportion of the overall plaque volume.16 In addition, the plaque cap is thin and the macrophage density high.17 18 Solid fibrous plaques (AHA type Vc) without a lipid core have no risk of disruption. The nature of the core material, which is rich in tissue factor produced by macrophages,19 enhances the thrombotic response when a lipid rich plaque undergoes disruption.
There is little work relating the characteristics that confer vulnerability, ie, a large core and thin cap,18 with factors such as stenosis and plaque size. It is known that an individual coronary artery usually contains a spectrum of plaques ranging from the lipid-rich to the fibrous in type.20 While most subjects have a spectrum of plaque types, some have a preponderance of one or other type.20 Previous studies of plaque composition have suggested that with increasing stenosis, the relative proportion of the plaque occupied by acellular fibrous tissue and the lipid core increases in a linear fashion.21 22 23
| Methods |
|---|
|
|
|---|
69 years old and had died suddenly of ischemic heart disease were studied. The subjects formed a consecutive series of patients who collapsed outside the hospital and who died in the receiving room of one hospital. Autopsy carried out by one of us (M.J.D.) showed no cause of death other than coronary artery disease. All had resuscitation attempted in the ambulance and/or receiving room. The mean age was 59 years, with a range of 46 to 69. Twenty-five of the subjects (81%) had experienced chest pain in the 6 hours before death. Prior (healed) myocardial infarction was found at necropsy in 2 (6%) and acute infarction in 4 (13%). Five patients (16%) had been clinically diagnosed as suffering from ischemic heart disease on the basis of a prior history of exertional angina. The coronary arteries were fixed by perfusion with 10% formaldehyde at a pressure of 120 mm Hg against the closed aortic valve for 24 hours. The arteries were then dissected intact from the heart and decalcified. The coronary arteries then were divided into 2-mm transverse slices throughout their entirety. These thin tissue slices then were analyzed for the area and diameter of the lumen with the use of an image analyzer (Analytical Medical Systems) with a Canon macrolens attached to a JVC TK-870E video camera. The depth of field of the lens allowed focusing on the point of maximal lumen narrowing. Lumen measurements were plotted against the distance from the ostium of the artery. Many plaques extended through more than one 2-mm segment. In such instances, the measurements were made at the point of maximum stenosis.
Tissue slices then were processed for histology. The segments were embedded in paraffin wax and each tissue block cut at four-step levels 500 µm apart to provide histological sections 6 µm in thickness. Sections were stained with Sirius red,22 23 which binds to collagen types I, II, and III and when viewed under polarized light produces very high contrast images. With the use of this technique, images not unlike those seen in intravascular ultrasound are produced (Fig 1
). The similarity is not surprising: Collagen surfaces are major reflectors of ultrasound. For all plaques, the sections were analyzed in the AMS system with use of the Optomax program. The plaque at the point of maximal lumen narrowing was outlined on the screen by the observer. With the use of automatic edge detection at a constant intensity of illumination, the size of the lipid core of the plaque not occupied by collagen then was measured as a percentage of the overall cross-sectional area of the plaque. The thickness (maximum and minimum) of the cap was measured with the use of the same system. Acute culprit lesions were excluded from analysis, as were 19 totally chronically occluded arteries that could not be perfusion-fixed. Data sets were compared with the use of simple linear regression to calculate an r value.
|
Forty-nine entire coronary arteries that contained 160 plaques of types IV and V were studied. Lesions of type I-III were not included in the study. Twenty-two of the 31 patients (71%) had a major thrombus occluding more than 30% of the lumen cross-sectional area at that point. These 22 plaques, taken to be the culprit lesion precipitating death, were excluded. Of these 22 plaques, 17 had undergone disruption with both an intraplaque thrombus and an intraluminal thrombus. Five of the 22 plaques had thrombosis as the result of erosion of the surface without an intraplaque component. A further 10 plaques were present in which there were small intraplaque recent thrombi; these were also excluded from the study. The exclusions ensured that only plaques in a stable phase were studied.
| Results |
|---|
|
|
|---|
|
|
|
|
| Discussion |
|---|
|
|
|---|
The time course of progression of coronary disease has been reported in a number of sequential angiographic studies.25 26 27 28 These studies have shown that progression is episodic and unpredictable. The sites at which the thrombotic lesions responsible for acute infarction develop are usually of moderate stenosis severity with a mean of 48% by diameter.29 A significant number both of the thrombotic occlusions and of the high-grade stenoses that develop between angiograms occur in arterial segments that were regarded as angiographically normal or mildly irregular in the first angiogram.30 The present study confirms that segments of artery in which the lumen is normal in size contain plaques. Of the 160 plaques studied, 55 (34.4%) would have been predicted to have been angiographically visible. Of these 55 plaques, 7% had lipid cores >50% of overall plaque volume and were thus at high risk for a disruption episode. The clinical angiographic data showing that new lesions can suddenly appear in normal arteries thus have a sound pathological explanation in that disruption of a previously occult vulnerable plaque has occurred. The present study, however, shows that vulnerable plaques occur across the full spectrum of severity of stenosis. However, disruption of a plaque causing minimal stenosis is more likely to invoke an acute ischemic episode because of the lack of prior collateral development.
The AHA-recommended classification4 23 of plaques has unified descriptions of lesions, allowing the work of different groups to be comparable. Nevertheless, within plaques that are types IV and Va with a lipid core and fibrous cap, there is still considerable heterogeneity in core size and cap thickness (Fig 2
). The lack of correlation between absolute plaque size, core size, and cap thickness may suggest that these variables are independent. Little is known of what determines core size, although death of lipid-filled macrophages by apoptosis is a potential mechanism for increasing the lipid core content.18 The factor determining cap thickness may be in part the activity of macrophages and in particular their production of metalloproteinases concerned with connective tissue degradation.31 32 33 34 A thick cap may reflect that local repair by smooth muscle cells producing collagen is in the ascendant.33 What appears established is that the concordance of a large core and a thin cap is the major determinant of plaque vulnerability.18 These parameters cannot be determined by angiography, although intravascular ultrasound and magnetic resonance may in the future become sufficiently sensitive to determine plaque characteristics in life.
Patient selection will inevitably influence the results of any study of plaque composition. This study selected subjects who were not chronically ill from heart failure and who died suddenly of ischemic heart disease outside the hospital. There was a low frequency of acute or old myocardial infarction. The subjects were still at a stage in which the coronary lesions were discrete and represent the moderate levels of disease found in many living symptomatic patients in whom the mechanisms of disease progression are of interest. Inclusion of patients with end-stage triple-vessel disease might well have produced data in which collagenous plaques are more predominant. The data reported by Kragel and colleagues34 35 36 also have related plaque constituents to the degree of stenosis in stable angina, unstable angina, and acute myocardial infarction. There was a linear increase in the mean proportion of the plaque occupied by acellular collagen and the lipid core with increasing stenosis. However, the use of mean data based on large numbers of plaques obscures the scatter of individual values. For this reason, in this study scatterplots were used. The studies by Kragel et al also included arteries in which the degree of stenosis was so great that chronic total occlusion was present. Fibrosis and smooth muscle proliferation is the ubiquitous repair response of the vessel wall and is the final common end point of disease progression. In the present study, such arteries were not included in the analysis because the purpose was to relate the plaque constituents to stenosis in patent arteries.
Individual patients vary in the proportion of plaque types that exist in their coronary arteries. While most patients have mixtures of all types of plaques, a small minority either have all fibrous or all lipid-rich plaques.20 The former may have slowly progressive stable angina as their main clinical expression; the latter have a very high risk of repeated acute ischemic episodes as the result of plaque disruption. Angiography, however, will not separate patients whose ultimate course will be to different ends of the clinical spectrum of ischemic heart disease, since it gives no information on plaque composition.
A limitation of the present study is the relatively small number of patients and lack of detailed knowledge of their lipid levels and risk profiles. They represent a small sample of white subjects without a known history of familial hypercholesterolemia or diabetes. Further studies are needed to ascertain whether the composition and distribution of plaque types in diabetics, nonwhite subjects, and men and women differ.
Received November 20, 1995; revision received February 21, 1996; accepted March 4, 1996.
| References |
|---|
|
|
|---|
2.
Tuzcu E, Hobbs R, Rincon G, Bott-Silverman C, De Franco AC, Robinson K, McCarthy PM, Stewart RW, Guyer S. Occult and frequent transmission of atherosclerotic coronary disease with cardiac transplantation: insights from intravascular ultrasound. Circulation. 1995;91:1706-1713.
3. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med. 1987;16:1371-1375.
4.
Stary HC, Chandler AB, Dinsmore RE, Fuster V. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis: a report from the committee on vascular lesions of the council on arteriosclerosis, American Heart Association. Circulation. 1995;92:1355-1374.
5.
Horie T, Sekiguchi M, Hirosawa K. Coronary thrombosis in pathogenesis of acute myocardial infarction: histopathological study of coronary arteries in 108 necropsied cases using serial section. Br Heart J. 1978;40:153-161.
6. Constantinides P. Plaque fissures in human coronary thrombosis. J Atheroscler Res. 1966;6:1-17.
7.
Davies M, Thomas A. Plaque fissuring: the cause of acute myocardial infarction, sudden ischaemic death and crescendo angina. Br Heart J. 1985;53:363-373.
8.
Falk E. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Circulation. 1985;71:699-708.
9.
Fuster V, Lewis A. Conner Memorial Lecture: mechanisms leading to myocardial infarction: insights from studies of vascular biology. Circulation. 1994;90:2126-2146.
10. Ambrose J, Winters S, Arora R, Haft J, Goldstein J, Rentrop K, Gorlin R. Coronary angiograph morphology in acute myocardial infarction: link between the pathogenesis of unstable angina and myocardial infarction. J Am Coll Cardiol. 1985;6:1233-1238.[Abstract]
11.
Levin D, Fallon J. Significance of the angiographic morphology of localized coronary stenosis: histopathologic correlations. Circulation. 1982;66:316-320.
12. Mizuno K, Satomura K, Miyamoto A, Arakawa K, Shibuya T, Arai T, Kurita A, Nakamura H. Angioscopic evaluation of coronary-artery thrombi in acute coronary syndromes. N Engl J Med. 1992;326:287-291.[Abstract]
13. Tracy R. The kind of plaque that underlies a coronary thrombosis. Am J Forensic Med Pathol. 1984;5:15-18.[Medline] [Order article via Infotrieve]
14. Tracy R, Devaney K, Kissling G. Characteristics of the plaque under a coronary thrombus. Virchows Arch Pathol Anat. 1985;405:411-427.
15. Escaned J, van Suylen RJ, MacLeod DC, Umans VA, de Jong M, Bosman FT, de Feyter PJ, Serruys PW. Histological characteristics of tissue excised during directional coronary atherectomy in stable and unstable angina pectoris. Am J Cardiol. 1993;71:1442-1447.[Medline] [Order article via Infotrieve]
16.
Davies MJ, Richardson PD, Woolf N, Katz DR, Mann JM. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage and smooth muscle cell content. Br Heart J. 1993;69:377-381.
17.
Moreno P, Falk E, Palacios I, Newell J, Fuster V, Fallon J. Macrophage infiltration in acute coronary syndromes: implications for plaque rupture. Circulation. 1994;90:775-778.
18.
Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation. 1995;92:657-671.
19. Fernandez-Ortiz A, Badimon JJ, Falk E, Fuster V, Mayer B, Mailhac A, Weng D, Shah PK. Characterization of the relative thrombogenicity of atherosclerotic plaque components: implication for consequences of plaque rupture. J Am Coll Cardiol. 1994;23:1562-1569.[Abstract]
20.
Hangartner J, Charleston A, Davies M, Thomas A. Morphological characteristics of clinically significant coronary artery stenosis in stable angina. Br Heart J. 1986;56:501-508.
21. Junqueira LCA, Bignolas G, Brentani R. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J. 1979;11:447-455.[Medline] [Order article via Infotrieve]
22. Junqueira LCA, Cossermelli W, Brentani R. Differential staining of collagens type I, II, III by Sirius red polarisation microscopy. Arch Histol Jpn. 1978;41:267-274.[Medline] [Order article via Infotrieve]
23.
Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W Jr, Rosenfeld ME, Schaffer SA, Schwartz CJ, Wagner WD, Wissler RW. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis: a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation. 1994;89:2462-2478.
24.
Mann JM, Davies MJ. Assessment of the severity of coronary artery disease at postmortem examination: are the measurements clinically valid? Br Heart J. 1995;74:528-530.
25. Bruschke AVG, Kramer JR, Bal ET, Haque I, Detranto RC, Goormastic M. The dynamics of progression of coronary atherosclerosis studied in 168 medically treated patients who underwent coronary arteriography three times. Am Heart J. 1989;117:296-305.[Medline] [Order article via Infotrieve]
26.
Lichtlen PR, Nikutta P, Jost S, Deckers J, Wiese B, Rafflenbeul W, INTACT Study Group. Anatomical progression of coronary artery disease in humans as seen by prospective, repeated, quantitated coronary angiography. Circulation. 1992;86:828-838.
27. Ambrose J, Tannenbaum M, Alexopoulos D, Hjemdahl CE, Borrico S, Gorlin R, Fuster V. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol. 1988;12:56-62.[Abstract]
28.
Hackett D, Davies G, Maseri A. Pre-existing coronary stenosis in patients with first myocardial infarction are not necessarily severe. Eur Heart J. 1988;9:1317-1323.
29.
Haft J, Haik B, Goldstein J, Brodyn N. Development of significant coronary artery lesions in areas of minimal disease: a common mechanism for coronary disease progression. Chest. 1988;94:731-736.
30.
Henney A, Wakeley P, Davies M, Foster K, Hembry R, Murphy G, Humphries S. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc Natl Acad Sci U S A. 1991;88:8154-8158.
31.
Galis Z, Sukhova G, Kranzhofer R, Clark S, Libby P. Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. Proc Natl Acad Sci U S A. 1995;92:402-406.
32.
Libby P. Molecular basis of the acute coronary syndromes. Circulation. 1995;91:2844-2850.
33. Galis Z, Sukhova G, Lark M, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest. 1994;94:2493-2503.
34.
Kragel AH, Reddy SG, Wittes JT, Roberts WC. Morphometric analysis of the composition of atherosclerotic plaques in the four major epicardial coronary arteries in acute myocardial infarction and in sudden coronary death. Circulation. 1989;80:1747-1756.
35. Kragel AH, Reddy SG, Wittes JT, Roberts WC. Morphometric analysis of the composition of coronary arterial plaques in isolated unstable angina pectoris with pain at rest. Am J Cardiol. 1990;66:562-567.[Medline] [Order article via Infotrieve]
36. Kragel AH, Gertz SD, Roberts WC. Morphologic comparison of frequency and types of acute lesions in the major epicardial coronary arteries in unstable angina pectoris, sudden coronary death and acute myocardial infarction. J Am Coll Cardiol. 1991;18:801-808.[Abstract]
This article has been cited by other articles:
![]() |
F.L. Lucas, A.E. Siewers, D.J. Malenka, and D.E. Wennberg Diagnostic-Therapeutic Cascade Revisited: Coronary Angiography, Coronary Artery Bypass Graft Surgery, and Percutaneous Coronary Intervention in the Modern Era Circulation, December 16, 2008; 118(25): 2797 - 2802. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Aldrovandi, F. Cademartiri, A. Menozzi, F. Ugo, D. Lina, E. Maffei, A. Palumbo, M. Fusaro, G. Crisi, and D. Ardissino Evaluation of Coronary Atherosclerosis by Multislice Computed Tomography in Patients With Acute Myocardial Infarction and Without Significant Coronary Artery Stenosis: A Comparative Study With Quantitative Coronary Angiography Circ Cardiovasc Imaging, November 1, 2008; 1(3): 205 - 211. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ishino, T. Mukai, Y. Kuge, N. Kume, M. Ogawa, N. Takai, J. Kamihashi, M. Shiomi, M. Minami, T. Kita, et al. Targeting of Lectinlike Oxidized Low-Density Lipoprotein Receptor 1 (LOX-1) with 99mTc-Labeled Anti-LOX-1 Antibody: Potential Agent for Imaging of Vulnerable Plaque J. Nucl. Med., October 1, 2008; 49(10): 1677 - 1685. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. W. Serruys, H. M. Garcia-Garcia, and E. Regar From Postmortem Characterization to the In Vivo Detection of Thin-Capped Fibroatheromas: The Missing Link Toward Percutaneous Treatment: What If Diogenes Would Have Found What He Was Looking For? J. Am. Coll. Cardiol., September 4, 2007; 50(10): 950 - 952. [Full Text] [PDF] |
||||
![]() |
L. Saba, G. Caddeo, R. Sanfilippo, R. Montisci, and G. Mallarini CT and Ultrasound in the Study of Ulcerated Carotid Plaque Compared with Surgical Results: Potentialities and Advantages of Multidetector Row CT Angiography AJNR Am. J. Neuroradiol., June 1, 2007; 28(6): 1061 - 1066. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Pundziute, J. D. Schuijf, J. W. Jukema, E. Boersma, A. J.H.A. Scholte, L. J.M. Kroft, E. E. van der Wall, and J. J. Bax Noninvasive Assessment of Plaque Characteristics With Multislice Computed Tomography Coronary Angiography in Symptomatic Diabetic Patients Diabetes Care, May 1, 2007; 30(5): 1113 - 1119. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Valgimigli, G. A. Rodriguez-Granillo, H. M. Garcia-Garcia, P. Malagutti, E. Regar, P. de Jaegere, P. de Feyter, and P. W. Serruys Distance from the ostium as an independent determinant of coronary plaque composition in vivo: an intravascular ultrasound study based radiofrequency data analysis in humans Eur. Heart J., March 2, 2006; 27(6): 655 - 663. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sdringola, C. Loghin, F. Boccalandro, and K. L. Gould Mechanisms of Progression and Regression of Coronary Artery Disease by PET Related to Treatment Intensity and Clinical Events at Long-Term Follow-up J. Nucl. Med., January 1, 2006; 47(1): 59 - 67. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Rodriguez-Granillo, H. M. Garcia-Garcia, E. P. Mc Fadden, M. Valgimigli, J. Aoki, P. de Feyter, and P. W. Serruys In Vivo Intravascular Ultrasound-Derived Thin-Cap Fibroatheroma Detection Using Ultrasound Radiofrequency Data Analysis J. Am. Coll. Cardiol., December 6, 2005; 46(11): 2038 - 2042. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Imoto, T. Hiro, T. Fujii, A. Murashige, Y. Fukumoto, G. Hashimoto, T. Okamura, J. Yamada, K. Mori, and M. Matsuzaki Longitudinal Structural Determinants of Atherosclerotic Plaque Vulnerability: A Computational Analysis of Stress Distribution Using Vessel Models and Three-Dimensional Intravascular Ultrasound Imaging J. Am. Coll. Cardiol., October 18, 2005; 46(8): 1507 - 1515. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ouhlous, H. Z. Flach, T. T. de Weert, J. M. Hendriks, M. R. H. M. van Sambeek, D. W. J. Dippel, P. M. T. Pattynama, and A. van der Lugt Carotid Plaque Composition and Cerebral Infarction: MR Imaging Study AJNR Am. J. Neuroradiol., May 1, 2005; 26(5): 1044 - 1049. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Sabatine and E. Braunwald Another look at the age-old question: Which came first, the elevated c-reactive protein or the atherothrombosis? J. Am. Coll. Cardiol., January 18, 2005; 45(2): 244 - 245. [Full Text] [PDF] |
||||
![]() |
J. A. Schaar, C. L. de Korte, F. Mastik, C. Strijder, G. Pasterkamp, E. Boersma, P. W. Serruys, and A. F.W. van der Steen Characterizing Vulnerable Plaque Features With Intravascular Elastography Circulation, November 25, 2003; 108(21): 2636 - 2641. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-C. Tardif, J. Gregoire, P.L. Lallier, and M. Joyal Chronic heart rate reduction with ivabradine and prevention of atherosclerosis progression assessed using intravascular ultrasound Eur. Heart J. Suppl., September 1, 2003; 5(suppl_G): G46 - G51. [Abstract] [PDF] |
||||
![]() |
J. Shemesh, S. Apter, Y. Itzchak, and M. Motro Coronary Calcification Compared in Patients with Acute versus in Those with Chronic Coronary Events by Using Dual-Sector Spiral CT Radiology, February 1, 2003; 226(2): 483 - 488. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Chase, M. Bond, M. F. Crook, and A. C. Newby Role of Nuclear Factor-{kappa}B Activation in Metalloproteinase-1, -3, and -9 Secretion by Human Macrophages In Vitro and Rabbit Foam Cells Produced In Vivo Arterioscler Thromb Vasc Biol, May 1, 2002; 22(5): 765 - 771. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wang, Y.-J. Geng, B. Guo, T. Klima, B. N. Lal, J. T. Willerson, and W. Casscells Near-infrared spectroscopic characterization of human advanced atherosclerotic plaques J. Am. Coll. Cardiol., April 17, 2002; 39(8): 1305 - 1313. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Beckman, J. Ganz, M. A. Creager, P. Ganz, and S. Kinlay Relationship of Clinical Presentation and Calcification of Culprit Coronary Artery Stenoses Arterioscler Thromb Vasc Biol, October 1, 2001; 21(10): 1618 - 1622. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Schroeder, A. F. Kopp, A. Baumbach, C. Meisner, A. Kuettner, C. Georg, B. Ohnesorge, C. Herdeg, C. D. Claussen, and K. R. Karsch Noninvasive detection and evaluation of atherosclerotic coronary plaques with multislice computed tomography J. Am. Coll. Cardiol., April 1, 2001; 37(5): 1430 - 1435. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.e. Helft, S. G. Worthley, V. Fuster, A. G. Zaman, C. Schechter, J. I. Osende, O. J. Rodriguez, Z. A. Fayad, J. T. Fallon, and J. J. Badimon Atherosclerotic aortic component quantification by noninvasive magnetic resonance imaging: an in vivo study in rabbits J. Am. Coll. Cardiol., March 15, 2001; 37(4): 1149 - 1154. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Burke, F. D. Kolodgie, A. Farb, D. K. Weber, G. T. Malcom, J. Smialek, and R. Virmani Healed Plaque Ruptures and Sudden Coronary Death : Evidence That Subclinical Rupture Has a Role in Plaque Progression Circulation, February 20, 2001; 103(7): 934 - 940. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sdringola, D. Patel, and K. L. Gould High Prevalence of Myocardial Perfusion Abnormalities on Positron Emission Tomography in Asymptomatic Persons With a Parent or Sibling With Coronary Artery Disease Circulation, January 30, 2001; 103(4): 496 - 501. [Abstract] [Full Text] [PDF] |
||||
![]() |
C von Birgelen, W Klinkhart, G S Mintz, H Wieneke, D Baumgart, M Haude, T Bartel, S Sack, J Ge, and R Erbel Size of emptied plaque cavity following spontaneous rupture is related to coronary dimensions, not to the degree of lumen narrowing. A study with intravascular ultrasound in vivo Heart, November 1, 2000; 84(5): 483 - 488. [Abstract] [Full Text] |
||||
![]() |
G. Pasterkamp, E. Falk, H. Woutman, and C. Borst Techniques characterizing the coronary atherosclerotic plaque: influence on clinical decision making? J. Am. Coll. Cardiol., July 1, 2000; 36(1): 13 - 21. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Saitoh, H. Kishida, Y. Tsukada, Y. Fukuma, J. Sano, M. Yasutake, N. Fukuma, Y. Kusama, and H. Hayakawa Clinical significance of increased plasma concentration of macrophage colony-stimulating factor in patients with angina pectoris J. Am. Coll. Cardiol., March 1, 2000; 35(3): 655 - 665. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Schmermund, A. E. Denktas, J. A. Rumberger, T. F. Christian, P. F. Sheedy II, K. R. Bailey, and R. S. Schwartz Independent and incremental value of coronary artery calcium for predicting the extent of angiographic coronary artery disease: Comparison with cardiac risk factors and radionuclide perfusion imaging J. Am. Coll. Cardiol., September 1, 1999; 34(3): 777 - 786. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Gibbons, K. Chatterjee, J. Daley, J. S. Douglas, S. D. Fihn, J. M. Gardin, M. A. Grunwald, D. Levy, B. W. Lytle, R. A. O'Rourke, et al. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina) J. Am. Coll. Cardiol., June 1, 1999; 33(7): 2092 - 2197. [Full Text] [PDF] |
||||
![]() |
A. P. Burke, A. Farb, G. T. Malcom, Y.-h. Liang, J. E. Smialek, and R. Virmani Plaque Rupture and Sudden Death Related to Exertion in Men With Coronary Artery Disease JAMA, March 10, 1999; 281(10): 921 - 926. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Gutstein and V. Fuster Pathophysiology and clinical significance of atherosclerotic plaque rupture Cardiovasc Res, February 1, 1999; 41(2): 323 - 333. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C Newby and A. B Zaltsman Fibrous cap formation or destruction -- the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation Cardiovasc Res, February 1, 1999; 41(2): 345 - 360. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Pasterkamp, A. H. Schoneveld, A. C. van der Wal, C. C. Haudenschild, R. J. G. Clarijs, A. E. Becker, B. Hillen, and C. Borst Relation of arterial geometry to luminal narrowing and histologic markers for plaque vulnerability: the remodeling paradox J. Am. Coll. Cardiol., September 1, 1998; 32(3): 655 - 662. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Fuster, J. J. Badimon, and J. H Chesebro Atherothrombosis: mechanisms and clinical therapeutic approaches Vascular Medicine, August 1, 1998; 3(3): 231 - 239. [Abstract] [PDF] |
||||
![]() |
K. Bhagat Endothelial function and myocardial infarction Cardiovasc Res, August 1, 1998; 39(2): 312 - 317. [Full Text] [PDF] |
||||
![]() |
J. A. Rumberger, R. Detrano, and T. Doherty Electron Beam CT and Coronary Calcium Score • Response Circulation, May 26, 1998; 97(20): 2095 - 2096. [Full Text] [PDF] |
||||
![]() |
M. B. DeYoung and D. A. Dichek Gene Therapy for Restenosis : Are We Ready? Circ. Res., February 23, 1998; 82(3): 306 - 313. [Abstract] [Full Text] [PDF] |
||||
![]() |
M J A Williams, N J Restieaux, and C J S Low Myocardial infarction in young people with normal coronary arteries Heart, February 1, 1998; 79(2): 191 - 194. [Abstract] [Full Text] |
||||
![]() |
J. A AMBROSE and V. FUSTER The risk of coronary occlusion is not proportional to the prior severity of coronary stenoses Heart, January 1, 1998; 79(1): 3 - 4. [Full Text] [PDF] |
||||
![]() |
A. Schmermund, D. Baumgart, G. Gorge, R. Seibel, D. Gronemeyer, J. Ge, M. Haude, J. Rumberger, and R. Erbel Coronary Artery Calcium in Acute Coronary Syndromes : A Comparative Study of Electron-Beam Computed Tomography, Coronary Angiography, and Intracoronary Ultrasound in Survivors of Acute Myocardial Infarction and Unstable Angina Circulation, September 2, 1997; 96(5): 1461 - 1469. [Abstract] [Full Text] |
||||
![]() |
M.J. Davies The Composition of Coronary-Artery Plaques N. Engl. J. Med., May 1, 1997; 336(18): 1312 - 1314. [Full Text] |
||||
![]() |
J. A. Ambrose and V. Fuster Can We Predict Future Acute Coronary Events in Patients With Stable Coronary Artery Disease? JAMA, January 22, 1997; 277(4): 343 - 344. [Abstract] [PDF] |
||||
![]() |
C. Yuan, L. M. Mitsumori, K. W. Beach, and K. R. Maravilla Carotid Atherosclerotic Plaque: Noninvasive MR Characterization and Identification of Vulnerable Lesions Radiology, November 1, 2001; 221(2): 285 - 299. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Verheye, G. R.Y. De Meyer, G. Van Langenhove, M. W.M. Knaapen, and M. M. Kockx In Vivo Temperature Heterogeneity of Atherosclerotic Plaques Is Determined by Plaque Composition Circulation, April 2, 2002; 105(13): 1596 - 1601. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1996 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |